Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04UIK
|
||||
Former ID |
DNC007467
|
||||
Drug Name |
MCL-429
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528655] | ||
Structure |
Download2D MOL |
||||
Formula |
C27H32N2O2
|
||||
Canonical SMILES |
C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)OC(=O)NC5=CC=CC=C5)CC6<br />CC6
|
||||
InChI |
1S/C27H32N2O2/c30-26(28-21-6-2-1-3-7-21)31-22-12-11-20-16-25-23-8-4-5-13-27(23,24(20)17-22)14-15-29(25)18-19-9-10-19/h1-3,6-7,11-12,17,19,23,25H,4-5,8-10,13-16,18H2,(H,28,30)
|
||||
InChIKey |
PNQVNINMHSUQSR-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [528655] | |
Kappa-type opioid receptor | Target Info | Inhibitor | [528655] | ||
Delta-type opioid receptor | Target Info | Inhibitor | [528655] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.